Perceptive Advisors - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 27 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$45,980,000
-89.9%
45,000,0000.0%1.33%
-90.7%
Q2 2022$455,940,000
-3.8%
45,000,0000.0%14.28%
+50.4%
Q1 2022$474,089,00045,000,0009.50%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Context Capital Management, LLC 41,167$26,7222.14%
SILVERBACK ASSET MANAGEMENT LLC 12,500,000$8,093,1881.11%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 26,500,000$17,217,3150.72%
BRAIDWELL LP 28,350,000$18,393,4800.58%
UBS OCONNOR LLC 25,000,000$16,144,7120.41%
WOLVERINE ASSET MANAGEMENT LLC 45,400,000$29,373,7290.33%
Lion Point Capital, LP 1,000,000$647,9300.29%
Segantii Capital Management Ltd 7,500,000$4,873,0850.17%
READYSTATE ASSET MANAGEMENT LP 3,000,000$1,946,4000.10%
CAPSTONE INVESTMENT ADVISORS, LLC 23,393,000$15,177,3780.07%
View complete list of TRAVERE THERAPEUTICS INC shareholders